PREVALENCE OF MICROSCOPIC TUMORS IN NORMAL APPEARING RENAL PARENCHYMA OF PATIENTS WITH HEREDITARY PAPILLARY RENAL CANCER-Reference-Cited by-同舟云学术

PREVALENCE OF MICROSCOPIC TUMORS IN NORMAL APPEARING RENAL PARENCHYMA OF PATIENTS WITH HEREDITARY PAPILLARY RENAL CANCER

Published:2000-02 Issue:2 Volume:163 Page:431-433
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

ORNSTEIN DAVID K.¹,LUBENSKY IRINA A.¹,VENZON DAVID¹,ZBAR BERTON¹,LINEHAN W. MARSTON¹,WALTHER McCLELLAN M.¹

Affiliation:

1. From the Urologic Oncology Branch, Laboratory of Pathology, and Biostatistics and Data Management Section, National Cancer Institute, Bethesda and Laboratory of Immunobiology, National Cancer Institute Frederick Cancer Research and Development Center, Frederick, Maryland

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference14 articles.

1. Molecular differential pathology of renal cell tumours;Kovacs;Histopathology,1993

2. Hereditary papillary renal cell carcinoma;Zbar;J Urol,1994

3. Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors;Delahunt;Mod Pathol,1997

4. Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics;Thoenes;Pathol Res Pract,1986

5. Hereditary papillary renal cell carcinoma: clinical studies in 10 families;Zbar;J Urol,1995

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hereditary papillary renal cell carcinoma;Seminars in Diagnostic Pathology;2024-01

2. Surgical Management of Hereditary Kidney Cancer Syndromes;Integrating Multidisciplinary Treatment for Advanced Renal Cell Carcinoma;2023

3. Tumorigenesis Mechanisms Found in Hereditary Renal Cell Carcinoma: A Review;Genes;2022-11-15

4. Opportunities and challenges of targeting c-Met in the treatment of digestive tumors;Frontiers in Oncology;2022-08-01

5. Roles of MET in human cancer;Clinica Chimica Acta;2022-01